Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial
==========================================================================================================================================================================================

* Dirk Schadendorf
* Jason John Luke
* Paolo A Ascierto
* Georgina V Long
* Piotr Rutkowski
* Adnan Khattak
* Michele Del Vecchio
* Luis de la Cruz-Merino
* Jacek Mackiewicz
* Vanna Chiarion Sileni
* John M Kirkwood
* Caroline Robert
* Jean-Jacques Grob
* Reinhard Dummer
* Matteo S Carlino
* Yujie Zhao
* Mizuho Kalabis
* Clemens Krepler
* Alexander Eggermont
* Richard A Scolyer